The EWAS carried out to date for NAFLD underscore the disruption of hepatic insulin signalling by DNA methylation as a major process underlying this disease, with many genes of this pathway showing differential methylation and associated changes in gene expression in NAFLD (some of which are highlighted in Figure 2). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.